{"id":"https://openalex.org/W2145898618","doi":"https://doi.org/10.1200/jco.2002.20.7.1951","title":"Enhanced Oral Bioavailability of Docetaxel by Coadministration of Cyclosporine: Quantitation and Role of P-Glycoprotein","display_name":"Enhanced Oral Bioavailability of Docetaxel by Coadministration of Cyclosporine: Quantitation and Role of P-Glycoprotein","publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W2145898618","doi":"https://doi.org/10.1200/jco.2002.20.7.1951","mag":"2145898618","pmid":"https://pubmed.ncbi.nlm.nih.gov/11919259"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2002.20.7.1951","doi":"https://doi.org/10.1200/jco.2002.20.7.1951","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2002.20.7.1951","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"letter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020089433","display_name":"Win Loung Chiou","orcid":"https://orcid.org/0000-0001-9599-8616","observed_orcids":["https://orcid.org/0000-0001-9599-8616"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Win L. Chiou","raw_affiliation_strings":["University of Illinois at Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110249721","display_name":"Ta C. Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ta Chen Wu","raw_affiliation_strings":["University of Illinois at Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019826145","display_name":"Chien Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chien Ma","raw_affiliation_strings":["University of Illinois at Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103025740","display_name":"Hyun Young Jeong","orcid":"https://orcid.org/0000-0002-2466-1044","observed_orcids":["https://orcid.org/0000-0002-2466-1044"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hyun Young Jeong","raw_affiliation_strings":["Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087232526","display_name":"Mirte M. Malingr\u00e9","orcid":"https://orcid.org/0000-0002-2531-3623","observed_orcids":["https://orcid.org/0000-0002-2531-3623"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.M. Malingr\u00e9","raw_affiliation_strings":["University of Illinois at Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.H. Beijnen","raw_affiliation_strings":["University of Illinois at Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000418012","display_name":"Jan H.M. Schellens","orcid":"https://orcid.org/0000-0001-6832-1976","observed_orcids":["https://orcid.org/0000-0001-6832-1976"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.H.M. Schellens","raw_affiliation_strings":["University of Illinois at Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago","institution_ids":["https://openalex.org/I39422238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"7","first_page":"1951","last_page":"1952"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9670000076293945},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9779999852180481},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9520000219345093},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.925000011920929},{"id":"https://openalex.org/keywords/cyp3a4-inhibition","display_name":"CYP3A4 inhibition","score":0.8069999814033508},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.824999988079071},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6150000095367432},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.7440000176429749},{"id":"https://openalex.org/keywords/drug-quantification","display_name":"pharmaceutical analysis","score":0.41200000047683716},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.42399999499320984},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibitors","display_name":"P-glycoprotein inhibitors","score":0.45100000500679016},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.3720000088214874}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7249860763549805},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7204143404960632},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6259292364120483},{"id":"https://openalex.org/C2778805511","wikidata":"https://www.wikidata.org/wiki/Q1713","display_name":"Citation","level":2,"score":0.5466837882995605},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4823700487613678},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4152609705924988},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4143965542316437},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3748479187488556},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3665352761745453},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.3304104506969452},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2002.20.7.1951","doi":"https://doi.org/10.1200/jco.2002.20.7.1951","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2002.20.7.1951","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:11919259","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11919259","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W80519939","https://openalex.org/W189829556","https://openalex.org/W1492893697","https://openalex.org/W1584222277","https://openalex.org/W1870564186","https://openalex.org/W1984820569","https://openalex.org/W2065519386","https://openalex.org/W2102903528","https://openalex.org/W2128936801","https://openalex.org/W2131452141","https://openalex.org/W2135538021","https://openalex.org/W2155223429","https://openalex.org/W2155315199","https://openalex.org/W2169427225","https://openalex.org/W2190657765","https://openalex.org/W2341593678","https://openalex.org/W4236009460","https://openalex.org/W4253898624","https://openalex.org/W4297820854"],"related_works":["https://openalex.org/W2155315199","https://openalex.org/W2169427225","https://openalex.org/W2035325818","https://openalex.org/W1511489281","https://openalex.org/W2135538021","https://openalex.org/W1966858550","https://openalex.org/W190801549","https://openalex.org/W4234638525","https://openalex.org/W2924824066","https://openalex.org/W7099779655"],"abstract_inverted_index":{"Article":[0,4],"Tools":[1,5],"SPECIAL":[2],"DEPARTMENTS":[3],"OPTIONS":[6],"&":[7,17],"TOOLS":[8],"Export":[9],"Citation":[10,12],"Track":[11],"Add":[13],"To":[14],"Favorites":[15],"Rights":[16],"Permissions":[18],"COMPANION":[19],"ARTICLES":[20],"No":[21],"companion":[22],"articles":[23,62,73,82,93,101,110,119],"ARTICLE":[24],"CITATION":[25],"DOI:":[26],"10.1200/JCO.2002.20.7.1951":[27],"Journal":[28],"of":[29,45,49,54,126,155,160,164,172,193,225,245,248,280,290,326,362,376,384,411,437,465,474,509,539,564,583,588,619,631,657,664,684,691,723,749,777,811,839],"Clinical":[30,156,161,165],"Oncology":[31],"-":[32],"published":[33,646],"online":[34],"before":[35],"print":[36],"September":[37],"21,":[38],"2016":[39],"PMID:":[40],"11919259":[41],"Enhanced":[42,717],"Oral":[43],"Bioavailability":[44],"Docetaxel":[46],"by":[47,63,74,83,94,102,111,120,152,191,261,295,304,310,332,340,414,569],"Coadministration":[48,656,748],"Cyclosporine:":[50],"Quantitation":[51],"and":[52,148,177,227,236,308,349,484,629,720,837],"Role":[53],"P-Glycoprotein":[55],"Win":[56],"L.":[57,59],"ChiouxWin":[58],"ChiouSearch":[60],"for":[61,72,81,92,100,109,118,278,373,614],"this":[64,75,84,95,103,112,121,276,353,441],"author":[65,76,85,96,104,113,122],",":[66,77,86,105,114],"Ta":[67],"Chen":[68,70],"WuxTa":[69],"WuSearch":[71],"Chien":[78],"MaxChien":[79],"MaSearch":[80],"Hyun":[87],"Young":[88,90],"JeongxHyun":[89],"JeongSearch":[91],"M.M.":[97],"Malingr\u00e9xM.M.":[98],"Malingr\u00e9Search":[99],"J.H.":[106],"BeijnenxJ.H.":[107],"BeijnenSearch":[108],"J.H.M.":[115],"SchellensxJ.H.M.":[116],"SchellensSearch":[117],"Show":[123],"More":[124,642],"University":[125],"Illinois":[127],"at":[128],"Chicago,":[129,130],"ILThe":[131],"Netherlands":[132,140],"Cancer":[133,698,732,759,788,820,847],"Institute/Antoni":[134],"van":[135,705,708,711,768,799,831],"Leeuwenhoek":[136],"Hospital,":[137],"Amsterdam,":[138],"the":[139,169,178,195,205,233,243,246,253,262,281,288,324,359,374,377,381,409,420,427,435,438,446,466,507,510,537,540,543,553,556,565,581,586,661,688,783,809],"https://doi.org/10.1200/JCO.2002.20.7.1951":[141],"First":[142],"Page":[143],"Full":[144],"Text":[145],"PDF":[146],"Figures":[147],"Tables":[149],"\u00a9":[150],"2002":[151],"American":[153],"Society":[154,163],"OncologyjcoJ":[157],"Clin":[158,667,731,758],"OncolJournal":[159],"OncologyJCO0732-183X1527-7755American":[162],"OncologyResponse01042002In":[166],"Reply:We":[167],"appreciate":[168],"valuable":[170],"remarks":[171],"Dr":[173],"Chiou":[174,269,305,333,573],"et":[175,270,306,334,574,654,680,715,746,773,802,834],"al":[176,271,307,335,575],"interest":[179],"they":[180],"took":[181],"in":[182,212,232,314,344,355,386,405,460,488,513,536,612,633,693,725,779,815],"our":[183,241,311,406,452],"recent":[184,312],"study.1":[185],"In":[186,490,596],"summary,":[187],"we":[188,400,454,500,604],"demonstrated":[189],"that":[190,275,321,532,555,576],"coadministration":[192,415],"cyclosporine,":[194,252,470],"systemic":[196,447],"exposure":[197],"to":[198,214,357,524,551,592,617],"oral":[199,215,360,393,450,463,600,638,662,689,718,750,754],"docetaxel":[200,256,291,342,348,385,458,486,518,601,632,692,840],"(indicated":[201],"as":[202,302,399,842],"area":[203],"under":[204],"plasma":[206,461],"concentration-time":[207],"curve":[208],"[AUC])":[209],"increased":[210],"7.3-fold":[211],"comparison":[213],"drug":[216,439,467,521,608,621],"ingestion":[217],"without":[218,640],"cyclosporine.":[219,296,350,389,641],"Cyclosporine":[220],"is":[221,284,292,298,396,422,443,534,567],"an":[222,491],"efficacious":[223],"inhibitor":[224],"P-glycoprotein":[226,560,577],"cytochrome":[228],"P450":[229],"(CYP)":[230],"3A4":[231],"gut":[234],"wall":[235],"liver,":[237],"which":[238],"may":[239,578],"explain":[240],"observations.1For":[242],"calculation":[244,375],"bioavailability":[247,283,329,361,379,413,663,690],"docetaxel,":[249,499,584],"coadministered":[250,364],"with":[251,365,380,388,416,482,494,497,516,572,728,756],"AUCoral":[254],"(oral":[255],"+":[257],"cyclosporine)":[258],"was":[259,622],"divided":[260],"AUCiv":[263],"(intravenous":[264],"docetaxel),":[265],"after":[266,449,462,506,637],"dose":[267],"correction.":[268],"rightly":[272],"point":[273],"out":[274],"procedure":[277],"estimation":[279],"true":[282,378],"only":[285,502],"justified":[286],"when":[287],"clearance":[289,325,383,436,538,563,582],"not":[293,299,371,444,456],"influenced":[294,568],"This":[297,480,529,624],"plausible,":[300],"however,":[301,471],"explained":[303],"substantiated":[309],"observations":[313],"mice.2":[315],"These":[316],"laboratory":[317],"studies":[318,407],"clearly":[319],"demonstrate":[320],"cyclosporine":[322],"decreases":[323,433],"docetaxel.":[327,665],"The":[328,390,682,804],"issue":[330,421],"stipulated":[331],"could":[336,455,477,501,530],"have":[337,401],"been":[338],"overcome":[339],"measuring":[341],"AUCs":[343],"patients":[345,495],"given":[346],"intravenous":[347,498,845],"We":[351],"followed":[352],"strategy":[354],"mice":[356,598,636,726,780],"investigate":[358],"paclitaxel":[363,412,724,778,814],"cyclosporine.3":[366],"However,":[367],"patient":[368],"data":[369,550,643],"were":[370],"available":[372],"total":[382],"combination":[387],"term":[391],"\u201capparent\u201d":[392],"bioavailability,":[394],"therefore,":[395],"more":[397,424],"applicable,":[398],"previously":[402],"defined,":[403],"also":[404,432,579,590],"on":[408,687],"enhancement":[410],"cyclosporine.2,4":[417],"For":[418],"paclitaxel,":[419,615],"even":[423],"complicated":[425],"because":[426],"pharmaceutical":[428,784],"vehicle":[429,785],"Cremophor":[430,786,806],"EL":[431,807],"substantially":[434],"while":[440],"excipient":[442],"entering":[445],"circulation":[448],"administration.4-6In":[451],"patients,":[453],"detect":[457],"metabolites":[459,476,504,566],"administration":[464,639],"alone.":[468],"With":[469],"significant":[472],"amounts":[473],"four":[475],"be":[478,593,645],"measured.":[479],"paralleled":[481],"low":[483],"high":[485,517],"levels":[487,519],"plasma.":[489],"earlier":[492],"study":[493],"treated":[496],"measure":[503],"shortly":[505],"end":[508],"1-hour":[511],"infusion":[512],"those":[514],"individuals":[515],"(low":[520],"clearance)":[522],"due":[523],"impaired":[525],"hepatic":[526],"liver":[527],"function.7":[528],"mean":[531],"CYP":[533,589],"involved":[535],"metabolites.":[541],"On":[542],"other":[544],"hand,":[545],"there":[546],"are":[547],"no":[548],"experimental":[549],"support":[552],"hypothesis":[554],"potential":[557],"CYP-":[558],"and/or":[559],"(other":[561],"transporters?)\u2013mediated":[562],"cyclosporine.We":[570],"agree":[571],"affect":[580],"although":[585],"effects":[587,683],"seem":[591],"very":[594],"prominent.2":[595],"wild-type":[597],"receiving":[599],"(without":[602],"cyclosporine),":[603],"recovered":[605],"38%":[606],"unchanged":[607,620],"(+":[609],"33%":[610],"metabolites)":[611],"feces;":[613],"80%":[616],"90%":[618],"found.2":[623],"indicates":[625],"both":[626],"substantial":[627],"absorption":[628,719,810],"metabolism":[630,838],"wild-type,":[634],"P-glycoprotein\u2013proficient":[635],"will":[644],"soon.1.":[647],"Malingr\u00e9":[648,742,795],"MM,":[649,743,796],"Richel":[650],"DJ,":[651],"Beijnen":[652,744],"JH,":[653,745],"al:":[655,681,716,747,774,803,835],"cyclosporin":[658,685,729,751],"strongly":[659],"enhances":[660],"J":[666,819],"Oncol":[668],"19::":[669],"1160,2001-1166,":[670],"Link,":[671],"Google":[672,703,737,764,793,825,854],"Scholar2.":[673],"Bardelmeijer":[674],"H,":[675,828],"Ouwehand":[676],"M,":[677],"Schellens":[678,797],"JHM,":[679,798],"A":[686,752],"mice.":[694],"Proc":[695],"Am":[696],"Assoc":[697],"Res":[699,733,760,789],"42::":[700],"951,,2001":[701],"(abstr)":[702],"Scholar3.":[704],"Asperen":[706],"J,":[707],"Tellingen":[709,769,800],"O,":[710,770,801],"der":[712],"Valk":[713],"MA,":[714],"decreased":[721],"elimination":[722],"co-treated":[727],"A.":[730],"4::":[734],"2293,1998-2299,":[735],"Medline,":[736,763,792,824,853],"Scholar4.":[738],"Meerum":[739],"Terwogt":[740],"JM,":[741],"enables":[753],"therapy":[755],"paclitaxel.":[757],"5::":[761],"3379,1999-3384,":[762],"Scholar5.":[765],"Sparreboom":[766],"A,":[767],"Nooijen":[771],"WJ,":[772],"Nonlinear":[775],"pharmacokinetics":[776],"results":[781],"from":[782],"EL.":[787],"56::":[790],"2112,1996-2115,":[791],"Scholar6.":[794],"co-solvent":[805],"limits":[808],"orally":[812],"administered":[813,841],"cancer":[816],"patients.":[817],"Br":[818],"85::":[821],"1472,2001-1477,":[822],"Crossref,":[823,852],"Scholar7.":[826],"Rosing":[827],"Lustig":[829],"V,":[830],"Warmerdam":[832],"LJC,":[833],"Pharmacokinetics":[836],"a":[843],"1-h":[844],"infusion.":[846],"Chemother":[848],"Pharmacol":[849],"45::":[850],"213,2000-218,":[851],"Scholar":[855]},"counts_by_year":[{"year":2018,"cited_by_count":2},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}